Taysha Gene Therapies Inc (TSHA) — Capital Reinvestment Ratio
Taysha Gene Therapies Inc (TSHA) has a Capital Reinvestment Ratio of 0.16x as of December 2022, meaning it reinvests 0% of its operating cash flow ($14.28 Million) in capital expenditures ($2.31 Million). See Taysha Gene Therapies Inc (TSHA) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Taysha Gene Therapies Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Taysha Gene Therapies Inc's Capital Reinvestment Ratio across 1 annual periods. Check Taysha Gene Therapies Inc (TSHA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Taysha Gene Therapies Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Taysha Gene Therapies Inc from 2019 to 2019. For live market cap and broader valuation context, see Taysha Gene Therapies Inc (TSHA) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.61x | $135.00K | $82.00K | — |